Abstract 3911: Targeting the EphA2-ligand binding domain for the design of innovative cancer therapeutics
Year: 2018
Type: conference-abstract
Source: Cancer Research
Institution: University of California, Riverside
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2885499833
